Innovative Solutions & Support, Inc. Announces Third Quarter Fiscal 2022 Revenues and Earnings
Innovative Solutions & Support, Inc. (NASDAQ: ISSC) reported third-quarter results ending June 30, 2022, with net sales of $6.9 million, a 12% increase from the previous year. Net income fell to $1.4 million ($0.08 per share) from $2.7 million ($0.16 per share) due to a prior tax benefit. Operating income rose 41% to $1.7 million. The firm added experienced board members and a new CFO. For the nine months, sales increased 26.6% to $20.5 million, with net income of $3.9 million ($0.23 per share).
- Net sales increased by 12% to $6.9 million in Q3 2022.
- Operating income rose by 41% to $1.7 million.
- Net income for the first nine months was $3.9 million, a slight increase from $3.5 million the previous year.
- Total sales increased by 26.6% to $20.5 million for the first nine months.
- Strong cash flow with $14.5 million in cash on hand.
- Net income decreased from $2.7 million to $1.4 million in Q3 2022 due to a lack of prior tax benefits.
- Earnings per share fell from $0.16 to $0.08 in Q3 2022.
For the third quarter of fiscal 2022, the Company reported net sales of
Cash Flow, New Orders and Backlog
The Company’s cash on hand increased to
New orders in the third quarter of fiscal 2022 were approximately
Nine Months Results
Total sales for the nine months ended
Conference Call
The Company will be hosting a conference call on
About
Headquartered in
Certain matters contained herein that are not descriptions of historical facts are "forward-looking" (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those discussed in filings made by the Company with the
Condensed Consolidated Statements of Operations |
||||||||||||||
|
||||||||||||||
|
|
|
||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||
|
||||||||||||||
Product |
$ |
6,935,976 |
$ |
5,981,462 |
|
$ |
20,279,371 |
$ |
15,886,967 |
|
||||
Engineering development contracts |
|
- |
|
198,721 |
|
|
198,203 |
|
284,713 |
|
||||
Total net sales |
|
6,935,976 |
|
6,180,183 |
|
|
20,477,574 |
|
16,171,680 |
|
||||
Cost of sales: |
||||||||||||||
Product |
|
2,879,462 |
|
2,764,765 |
|
|
8,253,981 |
|
7,270,708 |
|
||||
Engineering development contracts |
|
- |
|
60,916 |
|
|
16,748 |
|
77,656 |
|
||||
Total cost of sales |
|
2,879,462 |
|
2,825,681 |
|
|
8,270,729 |
|
7,348,364 |
|
||||
Gross profit |
|
4,056,514 |
|
3,354,502 |
|
|
12,206,845 |
|
8,823,316 |
|
||||
Operating expenses: |
||||||||||||||
Research and development |
|
676,381 |
|
646,795 |
|
|
2,062,937 |
|
1,936,747 |
|
||||
Selling, general and administrative |
|
1,694,233 |
|
1,512,138 |
|
|
5,226,015 |
|
4,847,410 |
|
||||
Total operating expenses |
|
2,370,614 |
|
2,158,933 |
|
|
7,288,952 |
|
6,784,157 |
|
||||
Operating income |
|
1,685,900 |
|
1,195,569 |
|
|
4,917,893 |
|
2,039,159 |
|
||||
Interest income |
|
10,429 |
|
107 |
|
|
10,871 |
|
1,138 |
|
||||
Other income |
|
21,608 |
|
17,231 |
|
|
49,401 |
|
50,994 |
|
||||
Income before income taxes |
|
1,717,937 |
|
1,212,907 |
|
|
4,978,165 |
|
2,091,291 |
|
||||
Income tax expense |
|
358,763 |
|
(1,473,014 |
) |
|
1,056,363 |
|
(1,443,352 |
) |
||||
|
|
|
|
|||||||||||
Net income |
$ |
1,359,174 |
$ |
2,685,921 |
|
$ |
3,921,802 |
$ |
3,534,643 |
|
||||
|
|
|
|
|||||||||||
Net income per common share: |
||||||||||||||
Basic |
$ |
0.08 |
$ |
0.16 |
|
$ |
0.23 |
$ |
0.21 |
|
||||
Diluted |
$ |
0.08 |
$ |
0.16 |
|
$ |
0.23 |
$ |
0.21 |
|
||||
Weighted average shares outstanding: |
||||||||||||||
Basic |
|
17,261,349 |
|
17,230,387 |
|
|
17,253,822 |
|
17,222,312 |
|
||||
Diluted |
|
17,265,798 |
|
17,231,438 |
|
|
17,255,305 |
|
17,223,908 |
|
||||
Condensed Consolidated Balance Sheets |
||||||||
|
|
|||||||
|
2022 |
|
|
2021 |
|
|||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ |
14,541,901 |
|
$ |
8,265,606 |
|
||
Accounts receivable |
|
3,003,362 |
|
|
4,046,337 |
|
||
Inventories |
|
4,905,034 |
|
|
4,545,392 |
|
||
Prepaid expenses and other current assets |
|
778,850 |
|
|
833,076 |
|
||
Assets held for sale |
|
1,558,475 |
|
|
- |
|
||
Total current assets |
|
24,787,622 |
|
|
17,690,411 |
|
||
Property and equipment, net |
|
6,381,461 |
|
|
8,143,483 |
|
||
Deferred income taxes |
|
278,085 |
|
|
1,063,822 |
|
||
Other assets |
|
168,900 |
|
|
188,284 |
|
||
|
|
|||||||
Total assets |
$ |
31,616,068 |
|
$ |
27,086,000 |
|
||
LIABILITIES AND SHAREHOLDERS' EQUITY |
||||||||
Current liabilities |
||||||||
Accounts payable |
$ |
752,479 |
|
$ |
623,620 |
|
||
Accrued expenses |
|
1,683,430 |
|
|
1,431,115 |
|
||
Contract liability |
|
329,116 |
|
|
417,504 |
|
||
|
|
|||||||
Total current liabilities |
|
2,765,025 |
|
|
2,472,239 |
|
||
Other liabilities |
|
18,407 |
|
|
28,680 |
|
||
|
|
|||||||
Total liabilities |
|
2,783,432 |
|
|
2,500,919 |
|
||
Commitments and contingencies (See Note 6) |
||||||||
Shareholders' equity |
||||||||
Preferred stock, 10,000,000 shares authorized, |
||||||||
200,000 shares are authorized as Class A Convertible stock. No shares |
||||||||
issued and outstanding at |
|
- |
|
|
- |
|
||
Common stock, |
||||||||
19,372,664 and 19,342,823 issued at |
|
19,373 |
|
|
19,343 |
|
||
Additional paid-in capital |
|
52,142,818 |
|
|
51,817,095 |
|
||
(Accumulated deficit) |
|
(1,961,018 |
) |
|
(5,882,820 |
) |
||
|
||||||||
and |
|
(21,368,537 |
) |
|
(21,368,537 |
) |
||
|
|
|||||||
Total shareholders' equity |
|
28,832,636 |
|
|
24,585,081 |
|
||
Total liabilities and shareholders' equity |
$ |
31,616,068 |
|
$ |
27,086,000 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220810005758/en/
610-646-9800 X550
Source:
FAQ
What were the financial results for ISSC in Q3 2022?
How did ISSC perform in the first nine months of fiscal year 2022?
What is the outlook for ISSC following the recent financial results?